erythrosine has been researched along with Graft vs Host Disease in 8 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The thymidine test was valid." | 1.36 | CFSE flow cytometric quantification of lymphocytic proliferation in extracorporeal photopheresis: use for quality control. ( Berger, M; Chassagne, J; Demeocq, F; Dosgilbert, A; Evrard, B; Gilles, T; Jacquemot, N; Tridon, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, J | 1 |
| Shen, Z | 1 |
| Peng, R | 1 |
| Li, C | 1 |
| Zhao, Y | 1 |
| Hu, B | 1 |
| Hong, J | 1 |
| Sega, EI | 1 |
| Leveson-Gower, DB | 1 |
| Florek, M | 1 |
| Schneidawind, D | 1 |
| Luong, RH | 1 |
| Negrin, RS | 1 |
| Choufi, B | 1 |
| Trauet, J | 1 |
| Thiant, S | 1 |
| Labalette, M | 1 |
| Yakoub-Agha, I | 1 |
| Faivre, L | 1 |
| Lecouflet, L | 1 |
| Liu, WQ | 1 |
| Khadher, I | 1 |
| Lahaie, C | 1 |
| Vidal, M | 1 |
| Legouvello, S | 1 |
| Beaumont, JL | 1 |
| Bierling, P | 1 |
| Rouard, H | 1 |
| Birebent, B | 1 |
| Evrard, B | 1 |
| Dosgilbert, A | 1 |
| Jacquemot, N | 1 |
| Demeocq, F | 1 |
| Gilles, T | 1 |
| Chassagne, J | 1 |
| Berger, M | 1 |
| Tridon, A | 1 |
| Godfrey, WR | 1 |
| Krampf, MR | 1 |
| Taylor, PA | 1 |
| Blazar, BR | 1 |
| Mori, S | 1 |
| Kocak, U | 1 |
| Shaw, JL | 1 |
| Mullen, CA | 1 |
| Pachnio, A | 1 |
| Dietrich, S | 1 |
| Klapper, W | 1 |
| Humpe, A | 1 |
| Schwake, M | 1 |
| Sedlacek, R | 1 |
| Gramatzki, M | 1 |
| Beck, C | 1 |
8 other studies available for erythrosine and Graft vs Host Disease
| Article | Year |
|---|---|
Tear Cytokines Associated With Therapeutic Effects in Chronic Ocular Graft-Versus-Host Disease.
Topics: Cytokines; Dry Eye Syndromes; Fluoresceins; Graft vs Host Disease; Humans; Interleukin-6; Interleuki | 2023 |
Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation.
Topics: Analysis of Variance; Animals; Antigens, CD; Bone Marrow Transplantation; Cell Proliferation; Flow C | 2014 |
Donor-derived CD4(+)/CCR7(+) T-cell partial selective depletion does not alter acquired anti-infective immunity.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; Cell Proliferation; C | 2014 |
Quality control of extracorporeal photochemotherapy: Proliferation assay using CFSE validated according to ISO 15189:2007 standards.
Topics: Cell Proliferation; Cells, Cultured; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Graft vs Host D | 2015 |
CFSE flow cytometric quantification of lymphocytic proliferation in extracorporeal photopheresis: use for quality control.
Topics: Cell Division; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Graft Rejection; Graft vs Host Diseas | 2010 |
Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation.
Topics: Animals; CD4-Positive T-Lymphocytes; Cell Separation; Dendritic Cells; Flow Cytometry; Fluoresceins; | 2004 |
Augmentation of post transplant immunity: antigen encounter at the time of hematopoietic stem cell transplantation enhances antigen-specific donor T-cell responses in the post transplant repertoire.
Topics: Animals; Antigens; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; Female; Flow Cytometry; | 2005 |
Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation.
Topics: Animals; B-Lymphocytes; Body Weight; Bone Marrow Transplantation; Cell Line, Tumor; Cell Proliferati | 2006 |